Alfaxalone-2-hydroxpropyl-β-cyclodextrin (alfaxalone-HPCD) was first marketed for veterinary use in Australia in 2001 and has since progressively became available throughout the world, including the USA, where in 2012 Food and Drug Administration (FDA) registration was granted. Despite the growing body of published works and increasing global availability of alfaxalone-HPCD, the accumulating evidence for its use in cats has not been thoroughly reviewed. The purpose of this review is: (1) to detail the pharmacokinetic properties of alfaxalone-HPCD in cats; (2) to assess the pharmacodynamic properties of alfaxalone-HPCD, including its cardiovascular, respiratory, central nervous system, neuromuscular, hepatic, renal, haematological, blood-biochemical, analgesic and endocrine effects; and (3) to consider the clinical application of alfaxalone-HPCD for sedation, induction and maintenance of anaesthesia in cats. Based on the published literature, alfaxalone-HPCD provides a good alternative to the existing intravenous anaesthetic options for healthy cats.

Few studies have been conducted examining male athletes and eating disorders, even though the sport environment may increase their risk. Thus, little information exists regarding the relationship of putative risk factors to eating disorders in this group. To address this issue, we examined the relationship of eating disorder classification to the risk factors of body image concerns (including drive for muscularity), negative affect, weight pressures, and disordered eating behaviors. Male college athletes (N= 199) from three different NCAA Division I universities participated. Only two athletes were classified with an eating disorder, though 33 (16.6%) and 164 (82.4%), respectively, were categorized as symptomatic and asymptomatic. Multivariate analyses revealed that eating disorder classification was unrelated to the majority of the risk factors, although the eating disorder group (i.e., clinical and symptomatic) did report greater fear of becoming fat, more weight pressures from TV and from magazines, and higher levels of stress than the asymptomatic athletes. In addition, the eating disorder group had higher scores on the Bulimia Test-Revised (Thelen, Mintz, & Vander Wal, 1996), which validated the Questionnaire for Eating Disorder Diagnosis (Mintz, O’Halloran, Mulholland, & Schneider, 1997) as a measure of eating disorders with male athletes. These findings suggest that variables that have been supported as risk factors among women in general, and female athletes in particular, may not apply as strongly, or at all, to male athletes.

RUMM block may be an effective technique to provide adjunctive analgesia for dogs undergoing surgery of the distal aspect of the thoracic limb.

No abstract

With female collegiate athletes, we examined the relationship of eating pathology to body image concerns, weight pressures, sociocultural internalization, and mood state. Multivariate analyses revealed that the symptomatic and eating disorder groups were similar on seven of eight weight pressures, three of four mood states, on internalization, and on five of six body image measures; in all instances, these two groups reported more pathological scores than the asymptomatic athletes. Except for pressures from coaches, the psychosocial variables differentiated the groups, correctly classifying 79% of the cases. These findings suggest that athletes symptomatic of eating disorders report similarly high levels of disturbance across a wide range of psychosocial risk factors, and both groups warrant prevention and treatment efforts.

Buprenorphine (0.02 mg/kg, IM) given before surgery and during wound closure provided adequate analgesia for 6 hours following ovariohysterectomy in cats, whereas butorphanol did not.

Previous research with female athletes has yielded equivocal findings when comparing disordered eating rates to nonathlete populations, but the rates differ for athletes in leanness and nonleanness sports (Sherman & Thompson, 2009). The purpose of the current study was to develop a measure to assess sport-specific weight pressures for female athletes. Secondly, this study identified frequencies of weight, size, and appearance pressures across sports. Participants (N =204) were female Division I athletes from three universities who represented 17 sports. Exploratory factor analysis yielded a 4-factor solution for the 16-item Weight Pressures in Sport for Females (WPS-F) scale with strong internal consistency (Cronbach’s alpha of 0.90). The most frequently reported pressures among female college athletes were teammates (36.8%), uniform (34.3%), and coach (33.8%). These findings are discussed in comparison with previous research along with clinical and research implications for using the WPS-F in sport psychology settings.

No abstract